Atrop-abyssomicin C
Atrop-abyssomicin C
Atrop-abyssomicin C is a natural product derived from the bacterium Verrucosispora strain AB-18-032. It belongs to the abyssomicin class of antibiotics and exhibits potent antibacterial activity against a variety of Gram-positive bacteria.
Discovery[edit | edit source]
Atrop-abyssomicin C was first isolated and characterized in 2007 by researchers studying the secondary metabolites produced by Verrucosispora strain AB-18-032. The discovery of this compound highlighted its unique chemical structure and promising antimicrobial properties.
Chemical Structure[edit | edit source]
The chemical structure of Atrop-abyssomicin C consists of a complex polycyclic core with multiple stereocenters. This structural complexity contributes to its biological activity and sets it apart from other antibiotics in its class.
Mechanism of Action[edit | edit source]
Atrop-abyssomicin C exerts its antibacterial effects by inhibiting the function of bacterial DNA gyrase, an essential enzyme involved in DNA replication and transcription. By targeting this specific molecular target, Atrop-abyssomicin C disrupts bacterial growth and proliferation.
Antibacterial Activity[edit | edit source]
Studies have demonstrated that Atrop-abyssomicin C exhibits potent antibacterial activity against a wide range of Gram-positive bacteria, including multidrug-resistant strains. Its efficacy against these pathogens makes it a promising candidate for the development of new antibiotics to combat antibiotic resistance.
Future Applications[edit | edit source]
The unique chemical structure and potent antibacterial activity of Atrop-abyssomicin C make it a valuable candidate for further research and development in the field of antibiotic discovery. Future studies may explore its potential clinical applications and therapeutic uses in treating bacterial infections.
References[edit | edit source]
1. Author A, Author B. (Year). Title of the Study. Journal Name, Volume(Issue), Page Range. 2. Author C, Author D. (Year). Title of the Article. Journal Name, Volume(Issue), Page Range.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD